Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Snijder

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|December 10, 1994
[Pulmonary hypertension following use of fenfluramine for obesity]B L Maesen, R J Snijder, B H Stricker
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Long-term efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertensionM C Post, H W M Plokker, J C Kelder, et al.
The Annals of Thoracic Surgery|February 10, 1998
Survival in resected stage I lung cancer with residual tumor at the bronchial resection marginR J Snijder, A Brutel de la Rivière, H J Elbers, et al.
International Journal of Cardiology. Heart & Vasculature|June 11, 2020
Does combination therapy work in chronic thromboembolic pulmonary hypertension?M C J van Thor, R J Snijder, J C Kelder, et al.
International Journal of Cardiology. Heart & Vasculature|March 13, 2019
Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertensionM C J van Thor, L Ten Klooster, R J Snijder, et al.
Respiratory Medicine|May 19, 2020
Long-term real world clinical outcomes of macitentan therapy in chronic thromboembolic pulmonary hypertensionM C J van Thor, L Ten Klooster, R J Snijder, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 27, 2002
[Pulmonary thromboendarterectomy: an effective surgical treatment for cor pulmonale due to chronic pulmonary emboli]R H Heijmen, S W van Haarlem, W J Morshuis, et al.
Chest|December 1, 1996
Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastasesE van Velzen, R J Snijder, A Brutel de la Rivière, et al.
Rhinology|April 23, 2009
The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot studyE M de Gussem, R J Snijder, F J Disch, et al.
The Annals of Thoracic Surgery|May 1, 1997
Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinomaE van Velzen, R J Snijder, A Brutel de la Rivière, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nederlands Tijdschrift Voor Geneeskunde|December 10, 1994
[Pulmonary hypertension following use of fenfluramine for obesity]B L Maesen, R J Snijder, B H Stricker
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Long-term efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertensionM C Post, H W M Plokker, J C Kelder, et al.
The Annals of Thoracic Surgery|February 10, 1998
Survival in resected stage I lung cancer with residual tumor at the bronchial resection marginR J Snijder, A Brutel de la Rivière, H J Elbers, et al.
International Journal of Cardiology. Heart & Vasculature|June 11, 2020
Does combination therapy work in chronic thromboembolic pulmonary hypertension?M C J van Thor, R J Snijder, J C Kelder, et al.
International Journal of Cardiology. Heart & Vasculature|March 13, 2019
Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertensionM C J van Thor, L Ten Klooster, R J Snijder, et al.
Respiratory Medicine|May 19, 2020
Long-term real world clinical outcomes of macitentan therapy in chronic thromboembolic pulmonary hypertensionM C J van Thor, L Ten Klooster, R J Snijder, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 27, 2002
[Pulmonary thromboendarterectomy: an effective surgical treatment for cor pulmonale due to chronic pulmonary emboli]R H Heijmen, S W van Haarlem, W J Morshuis, et al.
Chest|December 1, 1996
Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastasesE van Velzen, R J Snijder, A Brutel de la Rivière, et al.
Rhinology|April 23, 2009
The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot studyE M de Gussem, R J Snijder, F J Disch, et al.
The Annals of Thoracic Surgery|May 1, 1997
Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinomaE van Velzen, R J Snijder, A Brutel de la Rivière, et al.
Pageof 4